EPR studies on hydroxyl radical-scavenging activities of pravastatin and fluvastatin

Molecular and Cellular Biochemistry

Volumn 364, Issue 1-2, 2012, Pages 71-77

  Vandjelovic, Nathan ^a   Zhu, Hong ^a,b   Misra, Hara P ^a   Zimmerman, Ryan P ^a   Jia, Zhenquan ^c   Li, Yunbo ^a,b  

^a EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

DNA strand breaks; EPR; Hydroxyl radical; Statins

Indexed keywords

5,5 DIMETHYL 1 PYRROLINE 1 OXIDE; FERROUS ION; FERROUS SULFATE; FLUINDOSTATIN; HYDROGEN PEROXIDE; HYDROXYL RADICAL; PRAVASTATIN;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; ELECTRON SPIN RESONANCE; PLASMID; SPIN TRAPPING;

DNA BREAKS; ELECTRON SPIN RESONANCE SPECTROSCOPY; FATTY ACIDS, MONOUNSATURATED; FERROUS COMPOUNDS; FREE RADICAL SCAVENGERS; HUMANS; HYDROGEN PEROXIDE; HYDROXYL RADICAL; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INDOLES; PLASMIDS; PRAVASTATIN; REACTIVE OXYGEN SPECIES; SPIN TRAPPING;

EID: 84863987888     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-1206-6     Document Type: Article

References (38)

1. Heistad DD (2003) Unstable coronary-artery plaques. N Engl J Med 349:2285-2287 (Pubitemid 37509734)
2. Elrod JW, Lefer DJ (2005) The effects of statins on endothelium, inflammation and cardioprotection. Drug News Perspect 18:229-236 (Pubitemid 41094925)
3. Bloom HL, Shukrullah I, Veledar E, Gutmann R, London B, Dudley SC (2010) Statins decrease oxidative stress and ICD therapies. Cardiol Res Pract 2010:253803
4. Kuhn EW, Liakopoulos OJ, Borys MJ, Haldenwang PL, Strauch JT, Madershahian N, Choi YH, Wahlers T (2010) Statins improve surgical ablation outcomes for atrial fibrillation in patients undergoing concomitant cardiac surgery. Interact Cardiovasc Thorac Surg 11:24-38
5. Dimitrow PP, Jawien M (2010) Anti-inflammatory effect of atorvastatin in patients with aortic sclerosis or mild aortic stenosis independent of hypercholesterolemia. Pharmacol Rep 62:1250-1254
6. Boudreau DM, Yu O, Johnson J (2010) Statin use and cancer risk: a comprehensive review. Expert Opin Drug Saf 9:603-621
7. Gutt R, Tonlaar N, Kunnavakkam R, Karrison T, Weichselbaum RR, Liauw SL (2010) Statin use and risk of prostate cancer recurrence in men treated with radiation therapy. J Clin Oncol 28:2653-2659
8. Banez LL, Klink JC, Jayachandran J, Lark AL, Gerber L, Hamilton RJ, Masko EM, Vollmer RT, Freedland SJ (2010) Association between statins and prostate tumor inflammatory infiltrate in men undergoing radical prostatectomy. Cancer Epidemiol Biomarkers Prev 19:722-728
9. Platz EA, Till C, Goodman PJ, Parnes HL, Figg WD, Albanes D, Neuhouser ML, Klein EA, Thompson IM Jr, Kristal AR (2009) Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 18:2807-2813
10. Quist-Paulsen P (2010) Statins and inflammation: an update. Curr Opin Cardiol 25:399-405
11. Horiuchi Y, Hirayama S, Soda S, Seino U, Kon M, Ueno T, Idei M, Hanyu O, Tsuda T, Ohmura H, Miida T (2010) Statin therapy reduces inflammatory markers in hypercholesterolemic patients with high baseline levels. J Atheroscler Thromb 17:722-729
12. Li JJ, Li YS, Chu JM, Zhang CY, Wang Y, Huang Y, Chen J, Yuan JQ, Huang YL (2006) Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia. Clin Chim Acta 366:269-273 (Pubitemid 43330994)
13. Halliwell B (2006) Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiol 141:312-322 (Pubitemid 43974521)
14. Fitzpatrick FA (2001) Inflammation, carcinogenesis and cancer. Int Immunopharmacol 1:1651-1667 (Pubitemid 32772637)
15. Toyokuni S (2009) Role of iron in carcinogenesis: cancer as a ferrotoxic disease. Cancer Sci 100:9-16
16. Pryor WA, Houk KN, Foote CS, Fukuto JM, Ignarro LJ, Squadrito GL, Davies KJ (2006) Free radical biology and medicine: it's a gas, man! Am J Physiol Regul Integr Comp Physiol 291:R491-R511 (Pubitemid 44352329)
17. Goto I, Yamamoto-Yamaguchi Y, Honma Y (1996) Enhancement of sensitivity of human lung adenocarcinoma cells to growth-inhibitory activity of interferon alpha by differentiationinducing agents. Br J Cancer 74:546-554 (Pubitemid 26279048)
18. Pieper GM, Felix CC, Kalyanaraman B, Turk M, Roza AM (1995) Detection by ESR of DMPO hydroxyl adduct formation from islets of Langerhans. Free Radic Biol Med 19:219-225
19. Hsu CS, Li Y (2002) Aspirin potently inhibits oxidative DNA strand breaks: implications for cancer chemoprevention. Biochem Biophys Res Commun 293:705-709 (Pubitemid 34687244)
20. Jia Z, Zhu H, Li Y, Misra HP (2010) Potent inhibition of peroxynitriteinduced DNA strand breakage and hydroxyl radical formation by dimethyl sulfoxide at very low concentrations. Exp Biol Med (Maywood) 235:614-622
21. Buettner GR (1987) Spin trapping: ESR parameters of spin adducts. Free Radic Biol Med 3:259-303
22. Skogastierna C, Luksha L, Kublickiene K, Eliasson E, Rane A, Ekstrom L (2011) Beneficial vasoactive endothelial effects of fluvastatin: focus on prostacyclin and nitric oxide. Heart Vessels 26:628-636
23. Shuto H, Tominaga K, Yamauchi A, Ikeda M, Kusaba K, Mitsunaga D, Hirabara Y, Egawa T, Takano Y, Kataoka Y (2011) The statins fluvastatin and pravastatin exert anti-flushing effects by improving vasomotor dysfunction through nitric oxide-mediated mechanisms in ovariectomized animals. Eur J Pharmacol 651:234-239
24. Aoki C, Nakano A, Tanaka S, Yanagi K, Ohta S, Jojima T, Kasai K, Takekawa H, Hirata K, Hattori Y (2010) Fluvastatin upregulates endothelial nitric oxide synthase activity via enhancement of its phosphorylation and expression and via an increase in tetrahydrobiopterin in vascular endothelial cells. Int J Cardiol. doi: 10.1016/j.ijcard.2010.10.029
25. Davignon J, Jacob RF, Mason RP (2004) The antioxidant effects of statins. Coron Artery Dis 15:251-258 (Pubitemid 39061608)
26. Kaneider NC, Egger P, Dunzendorfer S, Wiedermann CJ (2002) Rho-GTPase-dependent platelet-neutrophil interaction affected by HMG-CoA reductase inhibition with altered adenosine nucleotide release and function. Arterioscler Thromb Vasc Biol 22:1029-1035 (Pubitemid 34655235)
27. Choi M, Rolle S, Rane M, Haller H, Luft FC, Kettritz R (2003) Extracellular signal-regulated kinase inhibition by statins inhibits neutrophil activation by ANCA. Kidney Int 63:96-106 (Pubitemid 35463910)
28. Puttananjaiah MK, Dhale MA, Gaonkar V, Keni S (2011) Statins: 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors demonstrate anti-atherosclerotic character due to their antioxidant capacity. Appl Biochem Biotechnol 163:215-222
29. Sagols E, Priymenko N (2011) Oxidative stress in dog with heart failure: the role of dietary fatty acids and antioxidants. Vet Med Int 2011:180206
30. Lakshmi SV, Padmaja G, Kuppusamy P, Kutala VK (2009) Oxidative stress in cardiovascular disease. Indian J Biochem Biophys 46:421-440
31. Siekmeier R, Lattke P, Mix C, Park JW, Jaross W (2001) Dose dependency of fluvastatin pharmacokinetics in serum determined by reversed phase HPLC. J Cardiovasc Pharmacol Ther 6:137-145 (Pubitemid 32977709)
32. Li Y, Trush MA (1993) DNA damage resulting from the oxidation of hydroquinone by copper: role for a Cu (II)/Cu (I) redox cycle and reactive oxygen generation. Carcinogenesis 14:1303-1311 (Pubitemid 23229672)
33. Shpyleva SI, Tryndyak VP, Kovalchuk O, Starlard-Davenport A, Chekhun VF, Beland FA, Pogribny IP (2011) Role of ferritin alterations in human breast cancer cells. Breast Cancer Res Treat 126:63-71
34. Callens C, Coulon S, Naudin J, Radford-Weiss I, Boissel N, Raffoux E, Wang PH, Agarwal S, Tamouza H, Paubelle E, Asnafi V, Ribeil JA, Dessen P, Canioni D, Chandesris O, Rubio MT, Beaumont C, Benhamou M, Dombret H, Macintyre E, Monteiro RC, Moura IC, Hermine O (2010) Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia. J Exp Med 207:731-750
35. Chua AC, Klopcic B, Lawrance IC, Olynyk JK, Trinder D (2010) Iron: an emerging factor in colorectal carcinogenesis. World J Gastroenterol 16:663-672
36. Heeba G, Moselhy ME, Hassan M, Khalifa M, Gryglewski R, Malinski T (2009) Anti-atherogenic effect of statins: role of nitric oxide, peroxynitrite and haem oxygenase-1. Br J Pharmacol 156:1256-1266
37. Cai L, Klein JB, Kang YJ (2000) Metallothionein inhibits peroxynitriteinduced DNA and lipoprotein damage. J Biol Chem 275:38957-38960 (Pubitemid 32058905)
38. Ruan RS (2002) Possible roles of nitric oxide in the physiology and pathophysiology of the mammalian cochlea. Ann N Y Acad Sci 962:260-274